Related Experiment Videos
Human hemopoietic progenitors and their signals
1Ontario Cancer Institute, Department of Medicine, University of Toronto, Canada.
Bone Marrow Transplantation
|January 1, 1991
Summary
Researchers identified human pluripotent hematopoietic stem cell candidates (CD34+, HLA-DR-). These cells regenerate bone marrow cultures and respond to interleukin signals, which can be dysregulated in cancer, potentially causing paraneoplastic syndromes.
Area of Science:
- Hematology
- Stem Cell Biology
- Oncology
Background:
- Recent advances have led to the identification of human pluripotent hematopoietic progenitors.
- These cells are potential candidates for stem cells, exhibiting specific surface markers (CD34 positive, HLA-DR negative).
Purpose of the Study:
- To characterize the properties and behavior of these candidate stem cells.
- To investigate their interaction with stromal cells and response to growth signals.
- To explore the role of aberrant interleukin production in malignant hematopoiesis and paraneoplastic syndromes.
Main Methods:
- Long-term bone marrow culture assays.
- Co-culture with irradiated stromal layers.
- Analysis of cell morphology and proliferation.
- Investigation of interleukin signaling pathways.
Main Results:
- Candidate stem cells re-established long-term bone marrow cultures.
- These cells demonstrated short-range interaction with stromal cells and responded to external signals.
- Interleukins, produced by auxiliary or malignant hematopoietic cells, were identified as key signaling molecules.
- Aberrant interleukin production was linked to autocrine/paracrine growth promotion and paraneoplastic syndromes.
Conclusions:
- Human pluripotent hematopoietic progenitors with stem cell potential have been defined.
- These cells interact with stromal cells and are regulated by interleukins.
- Dysregulated interleukin production in hematologic malignancies can drive cancer growth and paraneoplastic phenomena.